Legal Representation
Attorney
Patrick J. Jennings
USPTO Deadlines
Next Deadline
187 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20200623)
Due Date
June 23, 2026
Grace Period Ends
December 23, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 23, 2025 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Jun 23, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 19, 2020 | DP1B | I | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | Loading... |
| Apr 2, 2020 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
| May 13, 2020 | PC.D | I | PETITION TO DIRECTOR DISMISSED | Loading... |
| May 12, 2020 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Feb 18, 2020 | TPDR | I | TEAS PETITION TO DIRECTOR RECEIVED | Loading... |
| Feb 18, 2020 | TPDR | I | TEAS PETITION TO DIRECTOR RECEIVED | Loading... |
| Feb 18, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 18, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Feb 18, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 18, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 18, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jun 27, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 25, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 25, 2019 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jun 25, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 2, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 5, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 5, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 16, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 28, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 28, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 28, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 27, 2018 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 20, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 15, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 15, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 15, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 14, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 11, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 7, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for the treatment of cancer and autoimmune diseases; Sanitary preparations for medical purposes; Dietetic foods and beverages adapted for medical use; Medicines for human purposes, namely, medicines for treating cancer and autoimmune diseases; Chemical preparations for medical or pharmaceutical purposes, namely, treating cancer and autoimmune diseases; Vaccines; Serums; Chemical reagents for medical use; Disinfectants; Pharmaceutical preparations for the treatment of autoimmune diseases; Immunostimulants; Immunomodulators; Immunoassay reagents for medical use; Biological preparations for the treatment of cancer; Biological preparations for the treatment of cancer and autoimmune diseases; Monoclonal antibodies for use in disease testing
Class 042
Scientific and technological services, namely, research and design in the field of medicine and health; Design and development of software and data bases; Medical research; Research relating to biology and biotechnology; Pharmaceutical research services; Clinical research in the field of cancer and autoimmune diseases; Research and development services in the field of immunology; research and development in the field of microorganisms, cells and antibodies; Research and development of vaccines and medicines; biological analysis; Biological laboratory services; Advice on research and development in the field of therapeutics; Laboratory services relating to the production of monoclonal antibodies; Research and development services in the field of antibodies
Class 044
Provision of medical services; Advice relating to immunology; Therapy services in the nature of therapeutic health care services
Classification
International Classes
005
042
044